Tag: Breast

Categories
Health

Breast Implants Might Be Linked to Extra Cancers, F.D.A. Warns

Breast Implants May Be Linked to Additional Cancers, F.D.A. Warns

They are extremely rare, he added, and the new warning should not cause any general concern. Realizing that ALCL was associated with breast implants had already “allowed us to be more aware that other things might be happening in this area,” said Dr. Clemens.

“If ALCL is uncommon, these are very rare,” he added. It has long been known that scar tissue, such as that formed after breast implant surgery, can lead to squamous cell carcinoma, added Dr. added Clement.

“A wound that’s trying to heal and trying to heal for a long time can develop into these things,” he said. But the exact nature of the relationship between the implant and the cancer, and whether the implant causes the cancer, is not yet clear, he said.

In a typical year, approximately 400,000 women in the United States receive breast implants, 300,000 for cosmetic reasons and 100,000 for reconstruction after mastectomies performed to treat or prevent breast cancer.

Numbers dropped significantly in the first year of the pandemic, according to the American Society of Plastic Surgeons.

Last year, the FDA put so-called black-box labels on breast implants, warning that they have been linked to a variety of chronic conditions, including autoimmune diseases, joint pain, mental confusion, muscle pain and chronic fatigue to lymphoma.

Categories
Health

This Breast Most cancers Gene Is Much less Effectively Recognized, however Almost as Harmful

This Breast Cancer Gene Is Less Well Known, but Nearly as Dangerous

Heidi Marsh, 46, of Seattle, tested positive for the PALB2 mutation after her mother – a patient with breast and pancreatic cancer – was found to have it. She said her own doctor was unaware of the gene.

“My obstetrician was aware of my mother’s history and never suggested a genetic test,” Ms. Marsh said. “She’s never heard of it. I raised them. The oncologist she sent me to didn’t suggest an operation. “

But the Seattle Cancer Care Alliance, a partner at the Fred Hutchinson Cancer Research Center, where Ms. Marsh’s mother was an oncology nurse, knew about the gene mutation. The group immediately put together a team that consisted of a surgical oncologist, a pancreatic cancer specialist, a geneticist, a nutritionist, and a social worker.

“It changed life,” said Ms. Marsh, who had fallopian tubes removed in April. (She was told that most ovarian cancer occurs in the fallopian tubes first. She plans to have her ovaries removed after menopause.)

She will have breast monitoring with alternating mammograms and breast MRIs every six months. She already had an endoscopic ultrasound to examine her pancreas.

She found a Facebook group, PALB2 Warriors, to be helpful. Having a healthcare background – she was a phlebotomist – she says she looks beyond individual posts, to studies that are placebo-controlled and peer-reviewed to get information. But when it comes to personal testimonials with prophylactic mastectomies and reconstructions, this is invaluable.

“That wasn’t remotely on my radar screen,” she said. “In a way, I feel empowered. But I also have the feeling that I am waiting for the other shoe to fall, that cancer will be inevitable. “

But above all, she is grateful that she knows about PALB2 and the associated risks.

“It’s an alarm clock and a wake-up call,” she said. “You can do something about it if you want.”

Categories
Health

Vaccinated Moms Are Making an attempt to Give Kids Antibodies by way of Breast Milk

Vaccinated Mothers Are Trying to Give Children Antibodies via Breast Milk

In the first nine months of the pandemic, Unicef ​​estimates that around 116 million babies were born worldwide. This led researchers to scramble to answer a critical question: could the virus be transmitted through breast milk? Some people assumed it was possible. When several research groups tested the milk, they found no traces of viruses, only antibodies – suggesting that drinking the milk might protect babies from infection.

The next big question for breast milk researchers was whether the protective benefits of a Covid vaccine could similarly be transferred to babies. None of the vaccine studies included pregnant or breastfeeding women, so researchers had to find breastfeeding women who qualified for the first vaccine launch.

Through a Facebook group, Rebecca Powell, a breast milk immunologist at the Icahn School of Medicine on Mount Sinai in Manhattan, found hundreds of doctors and nurses willing to share their breast milk on a regular basis. In her most recent study, which was not officially published, she analyzed the milk of six women who received the Pfizer BioNTech vaccine and four women who received the Moderna vaccine 14 days after the women received their second shots had. She found a significant number of a specific antibody, called IgG, in all of them. Other researchers have found similar results.

“There is cause for concern,” said Dr. Kathryn Gray, a maternal fetal medicine specialist at Brigham and Women’s Hospital in Boston, has done similar studies. “We would assume that this could offer some level of protection.”

Updated

April 8, 2021, 11:48 a.m. ET

But how do we know exactly? One way of testing this – exposing these babies to the virus – is, of course, unethical. Instead, some researchers have tried to answer the question by studying the properties of the antibodies. Do they neutralize, which means they prevent the virus from infecting human cells?

In a draft small study, an Israeli researcher found that this was the case. “Breast milk has the ability to prevent the spread of viruses and block the virus’ ability to infect host cells that lead to disease,” wrote Yariv Wine, an applied immunologist at Tel Aviv University, in an email.

Research is too premature for vaccinated nursing mothers to pretend their babies can’t become infected, said Dr. Kirsi Jarvinen-Seppo, Senior Consultant Pediatric Allergy and Immunology at the University of Rochester Medical Center, conducted similar studies. “There is no direct evidence that the Covid antibodies in breast milk are protecting the child – only evidence that suggests it might,” she said.

Categories
Health

José Baselga, Who Superior Breast Most cancers Therapies, Dies at 61

José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61

José Baselga was born in Barcelona on July 3, 1959 and received his doctorate in medicine and doctorate from the Autonomous University of Barcelona. He caught the attention of cancer researchers after completing a medical fellowship at Memorial Sloan Kettering, where he and Dr. John Mendelsohn studied the use of monoclonal antibodies in fighting certain proteins associated with aggressive cancers, including lung and breast cancers.

Dr. Larry Norton, Senior Vice President at Memorial Sloan Kettering and Medical Director of the hospital’s Evelyn H. Lauder Breast Center, quickly became interested in Dr. Baselga and served as an early mentor. “He was an artist,” recalled Dr. Norton, adding that he “had a driving force within him and would focus all of his energies on achieving what is necessary to achieve that vision.”

Dr. Baselga returned to Spain in 1996 and founded the Vall d’Hebron Institute for Oncology at the Vall d’Hebron University Hospital in Barcelona. Under his leadership, the center became an international powerhouse in cancer research, testing targeted cancer therapies in early clinical trials. Dr. Baselga became a well-known figure in Spain.

“Spain was not known in the world as a place for research on cancer,” said Dr. Antoni Ribas, the president of the American Association for Cancer Research, who completed his medical training in Vall d’Hebron just before Dr. Baselga took over his role there. said in a telephone interview. “He put Vall d’Hebron, Barcelona and Spain on the map of cancer research.”

After a period from 2010 to 2013 at Massachusetts General Hospital, where he was director of the Department of Hematology and Oncology, Dr. Baselga returned to Memorial Sloan Kettering in 2013 to become chief physician and later chief physician.

He also held various leadership positions in the world of cancer research, including president of the American Association for Cancer Research and editor of Cancer Discovery and other medical journals.

Dr. Baselga resigned under pressure from Sloan Kettering in September 2018 after The Times and ProPublica, the nonprofit investigative journalism outfit, reported that it failed to disclose millions of dollars in drug and health company payments in dozens of research articles in The New England Journal of Medicine and other publications.